{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:45:50Z","timestamp":1791297950747,"version":"4.1.0"},"reference-count":102,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acquired and congenital aplastic anemias recently have been linked molecularly and pathophysiologically by abnormal telomere maintenance. Telomeres are repeated nucleotide sequences that cap the ends of chromosomes and protect them from damage. Telomeres are eroded with cell division, but in hematopoietic stem cells, maintenance of their length is mediated by telomerase. Accelerated telomere shortening is virtually universal in dyskeratosis congenita, caused by mutations in genes encoding components of telomerase or telomere-binding protein (TERT, TERC, DKC1, NOP10, or TINF2). About one-third of patients with acquired aplastic anemia also have short telomeres, which in some cases associate with TERT or TERC mutations. These mutations cause low telomerase activity, accelerated telomere shortening, and diminished proliferative capacity of hematopoietic progenitors. As in other genetic diseases, additional environmental, genetic, and epigenetic modifiers must contribute to telomere erosion and ultimately to disease phenotype. Short telomeres also may cause genomic instability and malignant progression in these marrow failure syndromes. Identification of short telomeres has potential clinical implications: it may be useful in dyskeratosis congenita diagnosis, in suggesting mutations in patients with acquired aplastic anemia, and for selection of suitable hematopoietic stem cell family donors for transplantation in telomerase-deficient patients.<\/jats:p>","DOI":"10.1182\/blood-2007-08-019729","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T21:36:32Z","timestamp":1201815392000},"page":"4446-4455","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":187,"title":["Telomere maintenance and human bone marrow failure"],"prefix":"10.1182","volume":"111","author":[{"given":"Rodrigo T.","family":"Calado","sequence":"first","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Young","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111715423664700_B1","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood.V91.10.3582","article-title":"Progressive telomere shortening in aplastic anemia.","volume":"91","author":"Ball","year":"1998","journal-title":"Blood"},{"key":"2019111715423664700_B2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V97.4.895","article-title":"Telomere length in leukocyte subpopulations of patients with aplastic anemia.","volume":"97","author":"Brummendorf","year":"2001","journal-title":"Blood"},{"key":"2019111715423664700_B3","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1046\/j.1365-2141.2001.02669.x","article-title":"Telomere length changes in patients with aplastic anaemia.","volume":"112","author":"Lee","year":"2001","journal-title":"Br J Haematol"},{"key":"2019111715423664700_B4","first-page":"S30","article-title":"Accelerated telomerase shortening and telomerase activation in Fanconi's anemia.","volume":"23","author":"Leteurtre","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"2019111715423664700_B5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1365-2141.2003.04225.x","article-title":"Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia.","volume":"120","author":"li","year":"2003","journal-title":"Br J Haematol"},{"key":"2019111715423664700_B6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/990141","article-title":"A telomerase component is defective in the human disease dyskeratosis congenita.","volume":"402","author":"Mitchell","year":"1999","journal-title":"Nature"},{"key":"2019111715423664700_B7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/bcmd.2001.0389","article-title":"Very short telomeres in the peripheral blood of patients with x-linked and autosomal dyskeratosis congenita.","volume":"27","author":"Vulliamy","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"2019111715423664700_B8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2141.2002.03371.x","article-title":"Abnormal telomere shortening in leucocytes of children with Shwachman-Diamond syndrome.","volume":"117","author":"Thornley","year":"2002","journal-title":"Br J Haematol"},{"key":"2019111715423664700_B9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat Genet"},{"key":"2019111715423664700_B10","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia.","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"key":"2019111715423664700_B11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.seminhematol.2006.04.005","article-title":"Fanconi anemia.","volume":"43","author":"Bagby","year":"2006","journal-title":"Semin Hematol"},{"key":"2019111715423664700_B12","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood-2005-10-4240","article-title":"Molecular pathogenesis of Fanconi anemia: recent progress.","volume":"107","author":"Taniguchi","year":"2006","journal-title":"Blood"},{"key":"2019111715423664700_B13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.seminhematol.2006.04.001","article-title":"Dyskeratosis congenita.","volume":"43","author":"Vulliamy","year":"2006","journal-title":"Semin Hematol"},{"key":"2019111715423664700_B14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.seminhematol.2006.04.006","article-title":"Shwachman-Diamond syndrome.","volume":"43","author":"Shimamura","year":"2006","journal-title":"Semin Hematol"},{"key":"2019111715423664700_B15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrm1961","article-title":"The biogenesis and regulation of telomerase holoenzymes.","volume":"7","author":"Collins","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2019111715423664700_B16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0092-8674(01)00492-5","article-title":"Switching and signaling at the telomere.","volume":"106","author":"Blackburn","year":"2001","journal-title":"Cell"},{"key":"2019111715423664700_B17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.emboj.7600598","article-title":"Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging.","volume":"24","author":"Blasco","year":"2005","journal-title":"EMBO J"},{"key":"2019111715423664700_B18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev.biochem.75.103004.142412","article-title":"The structure and function of telomerase reverse transcriptase [review].","volume":"75","author":"Autexier","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"2019111715423664700_B19","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1101\/gad.1346005","article-title":"Shelterin: the protein complex that shapes and safeguards human telomeres.","volume":"19","author":"de Lange","year":"2005","journal-title":"Genes Dev"},{"key":"2019111715423664700_B20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature05469","article-title":"TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase.","volume":"445","author":"Xin","year":"2007","journal-title":"Nature"},{"key":"2019111715423664700_B21","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1073\/pnas.85.18.6622","article-title":"A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.","volume":"85","author":"Moyzis","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715423664700_B22","first-page":"1","article-title":"A history of telomere biology.","volume-title":"Telomeres","author":"Blackburn","year":"2006"},{"key":"2019111715423664700_B23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/newbio239197a0","article-title":"Origin of concatemeric T7 DNA.","volume":"239","author":"Watson","year":"1972","journal-title":"Nat New Biol"},{"key":"2019111715423664700_B24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-5193(73)90198-7","article-title":"A theory of marginotomy: the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon.","volume":"41","author":"Olovnikov","year":"1973","journal-title":"J Theor Biol"},{"key":"2019111715423664700_B25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0968-0004(02)02110-2","article-title":"Oxidative stress shortens telomeres.","volume":"27","author":"von Zglinicki","year":"2002","journal-title":"Trends Biochem Sci"},{"key":"2019111715423664700_B26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence.","volume":"426","author":"d'Adda di Fagagna","year":"2003","journal-title":"Nature"},{"key":"2019111715423664700_B27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1097-2765(04)00256-4","article-title":"Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).","volume":"14","author":"Herbig","year":"2004","journal-title":"Mol Cell"},{"key":"2019111715423664700_B28","doi-asserted-by":"crossref","first-page":"9028","DOI":"10.1128\/MCB.20.23.9028-9040.2000","article-title":"Human H\/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10.","volume":"20","author":"Pogacic","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2019111715423664700_B29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0092-8674(85)90170-9","article-title":"Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.","volume":"43","author":"Greider","year":"1985","journal-title":"Cell"},{"key":"2019111715423664700_B30","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1126\/science.1138596","article-title":"Protein composition of catalytically active human telomerase from immortal cells.","volume":"315","author":"Cohen","year":"2007","journal-title":"Science"},{"key":"2019111715423664700_B31","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1096\/fasebj.13.15.2091","article-title":"Studies of the molecular mechanisms in the regulation of telomerase activity.","volume":"13","author":"Liu","year":"1999","journal-title":"FASEB J"},{"key":"2019111715423664700_B32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2005.05.009","article-title":"Hormones and growth factors regulate telomerase activity in ageing and cancer.","volume":"240","author":"Bayne","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"2019111715423664700_B33","doi-asserted-by":"crossref","first-page":"33436","DOI":"10.1074\/jbc.273.50.33436","article-title":"Telomerase is controlled by protein kinase Calpha in human breast cancer cells.","volume":"273","author":"Li","year":"1998","journal-title":"J Biol Chem"},{"key":"2019111715423664700_B34","doi-asserted-by":"crossref","first-page":"16729","DOI":"10.1074\/jbc.272.27.16729","article-title":"Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells.","volume":"272","author":"Li","year":"1997","journal-title":"J Biol Chem"},{"key":"2019111715423664700_B35","doi-asserted-by":"crossref","first-page":"641a","DOI":"10.1182\/blood.V106.11.2276.2276","article-title":"Sex hormones up-regulate telomerase activity of normal human hematopoietic cells and restore telomerase activity in carriers of telomerase complex mutations [abstract].","volume":"106","author":"Calado","year":"2005","journal-title":"Blood"},{"key":"2019111715423664700_B36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(01)80006-4","article-title":"Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.","volume":"91","author":"Blasco","year":"1997","journal-title":"Cell"},{"key":"2019111715423664700_B37","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1128\/MCB.24.16.7024-7031.2004","article-title":"Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo.","volume":"24","author":"Chiang","year":"2004","journal-title":"Mol Cell Biol"},{"key":"2019111715423664700_B38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2005.11.020","article-title":"Short telomeres, even in the presence of telomerase, limit tissue renewal capacity [abstract].","volume":"123","author":"Hao","year":"2005","journal-title":"Cell"},{"key":"2019111715423664700_B39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0092-8674(00)80580-2","article-title":"Longevity, stress response, and cancer in aging telomerase-deficient mice.","volume":"96","author":"Rudolph","year":"1999","journal-title":"Cell"},{"key":"2019111715423664700_B40","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/78595","article-title":"Mice without telomerase: what can they teach us about human cancer?","volume":"6","author":"Artandi","year":"2000","journal-title":"Nat Med"},{"key":"2019111715423664700_B41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/302446","article-title":"X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.","volume":"65","author":"Knight","year":"1999","journal-title":"Am J Hum Genet"},{"key":"2019111715423664700_B42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/35096585","article-title":"The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.","volume":"413","author":"Vulliamy","year":"2001","journal-title":"Nature"},{"key":"2019111715423664700_B43","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1182\/blood-2006-12-062851","article-title":"Telomerase reverse transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.","volume":"110","author":"Marrone","year":"2007","journal-title":"Blood"},{"key":"2019111715423664700_B44","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/hmg\/ddm111","article-title":"Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.","volume":"16","author":"Walne","year":"2007","journal-title":"Hum Mol Genet"},{"key":"2019111715423664700_B45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2019111715423664700_B46","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2004-09-3659","article-title":"Functional characterization of telomerase RNA variants found in patients with hematological disorders.","volume":"105","author":"Ly","year":"2005","journal-title":"Blood"},{"key":"2019111715423664700_B47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1182\/blood-2006-07-035089","article-title":"Functional characterization of natural telomerase mutations found in patients with hematological disorders.","volume":"109","author":"Xin","year":"2007","journal-title":"Blood"},{"key":"2019111715423664700_B48","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1101\/gad.1476206","article-title":"Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.","volume":"20","author":"Wong","year":"2007","journal-title":"Genes Dev"},{"key":"2019111715423664700_B49","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1128\/MCB.23.19.6849-6856.2003","article-title":"Comprehensive structure-function analysis of the core domain of human telomerase RNA.","volume":"23","author":"Ly","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2019111715423664700_B50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/07391102.2007.10531238","article-title":"The impact of dyskeratosis congenita mutations on the structure and dynamics of the human telomerase RNA pseudoknot domain.","volume":"24","author":"Yingling","year":"2007","journal-title":"J Biomol Struct Dyn"},{"key":"2019111715423664700_B51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng1346","article-title":"Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.","volume":"36","author":"Vulliamy","year":"2004","journal-title":"Nat Genet"},{"key":"2019111715423664700_B52","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1182\/blood.V99.8.2767","article-title":"Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells.","volume":"99","author":"Samper","year":"2002","journal-title":"Blood"},{"key":"2019111715423664700_B53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ng0598-6","article-title":"Dyskeratosis and ribosomal rebellion.","volume":"19","author":"Luzzatto","year":"1998","journal-title":"Nat Genet"},{"key":"2019111715423664700_B54","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1182\/blood-2005-12-4831","article-title":"Ribosomes and marrow failure: coincidental association or molecular paradigm?","volume":"107","author":"Liu","year":"2006","journal-title":"Blood"},{"key":"2019111715423664700_B55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1126\/science.1079447","article-title":"Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.","volume":"299","author":"Ruggero","year":"2003","journal-title":"Science"},{"key":"2019111715423664700_B56","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1126\/science.1123835","article-title":"Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.","volume":"312","author":"Yoon","year":"2006","journal-title":"Science"},{"key":"2019111715423664700_B57","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms.","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"key":"2019111715423664700_B58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.gde.2005.04.004","article-title":"Dyskeratosis congenita: telomerase, telomeres and anticipation.","volume":"15","author":"Marrone","year":"2005","journal-title":"Curr Opin Genet Dev"},{"key":"2019111715423664700_B59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/asheducation-2006.1.63","article-title":"Inherited bone marrow failure syndromes: molecular features.","author":"Shimamura","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2019111715423664700_B60","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(02)09087-6","article-title":"Association between aplastic anaemia and mutations in telomerase RNA.","volume":"359","author":"Vulliamy","year":"2002","journal-title":"Lancet"},{"key":"2019111715423664700_B61","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0140-6736(03)14797-6","article-title":"Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.","volume":"362","author":"Fogarty","year":"2003","journal-title":"Lancet"},{"key":"2019111715423664700_B62","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood-2003-01-0335","article-title":"Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.","volume":"102","author":"Yamaguchi","year":"2003","journal-title":"Blood"},{"key":"2019111715423664700_B63","first-page":"707","article-title":"TERC mutations in children with refractory cytopenia.","volume":"91","author":"Ortmann","year":"2006","journal-title":"Haematologica"},{"key":"2019111715423664700_B64","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(02)11551-0","article-title":"Aplastic anaemia and telomerase RNA mutations.","volume":"360","author":"Calado","year":"2002","journal-title":"Lancet"},{"key":"2019111715423664700_B65","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa042980","article-title":"Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.","volume":"352","author":"Yamaguchi","year":"2005","journal-title":"N Engl J Med"},{"key":"2019111715423664700_B66","doi-asserted-by":"crossref","first-page":"15960","DOI":"10.1073\/pnas.0508124102","article-title":"Haplionsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.","volume":"102","author":"Armanios","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715423664700_B67","first-page":"656","article-title":"Mutations in telomerase catalytic protein in Japanese children with aplastic anemia.","volume":"91","author":"Liang","year":"2006","journal-title":"Haematologica"},{"key":"2019111715423664700_B68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bcmd.2004.12.008","article-title":"Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.","volume":"34","author":"Vulliamy","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"2019111715423664700_B69","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.exphem.2006.02.008","article-title":"Genetic variation in telomeric repeat binding factor 1 and 2 in aplastic anemia.","volume":"34","author":"Savage","year":"2006","journal-title":"Exp Hematol"},{"key":"2019111715423664700_B70","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase mutations in families with idiopathic pulmonary fibrosis.","volume":"356","author":"Armanios","year":"2007","journal-title":"N Engl J Med"},{"key":"2019111715423664700_B71","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(04)16724-X","article-title":"In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.","volume":"364","author":"Risitano","year":"2004","journal-title":"Lancet"},{"key":"2019111715423664700_B72","doi-asserted-by":"crossref","first-page":"307a","DOI":"10.1182\/blood.V106.11.1052.1052","article-title":"Evidence for T-cell oligoclonal expansion in aplastic anemia associated with telomerase complex mutations: pathophysiological and clinical implications [abstract].","volume":"106","author":"Calado","year":"2005","journal-title":"Blood"},{"key":"2019111715423664700_B73","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1183\/09031936.06.00087005","article-title":"Telomere shortening in smokers with and without COPD.","volume":"27","author":"Morla","year":"2006","journal-title":"Eur Respir J"},{"key":"2019111715423664700_B74","doi-asserted-by":"crossref","first-page":"17312","DOI":"10.1073\/pnas.0407162101","article-title":"Accelerated telomere shortening in response to life stress.","volume":"101","author":"Epel","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715423664700_B75","doi-asserted-by":"crossref","first-page":"13782","DOI":"10.1073\/pnas.94.25.13782","article-title":"In vivo telomere dynamics of human hematopoietic stem cells.","volume":"94","author":"Notaro","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715423664700_B76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1566524053586554","article-title":"Telomere dynamics in response to chemotherapy [abstract].","volume":"5","author":"Beeharry","year":"2005","journal-title":"Curr Mol Med"},{"key":"2019111715423664700_B77","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jlb.52.3.357","article-title":"Release of active oxygen radicals by leukocytes of Fanconi anemia patients.","volume":"52","author":"Korkina","year":"1992","journal-title":"J Leukoc Biol"},{"key":"2019111715423664700_B78","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1371\/journal.pbio.0050110","article-title":"Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence.","volume":"5","author":"Passos","year":"2007","journal-title":"PLoS Biol"},{"key":"2019111715423664700_B79","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/hmg\/11.4.439","article-title":"Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia.","volume":"11","author":"Callen","year":"2002","journal-title":"Hum Mol Genet"},{"key":"2019111715423664700_B80","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1126\/science.1103619","article-title":"Defective telomere lagging strand synthesis in cells lacking WRN helicase activity.","volume":"306","author":"Crabbe","year":"2004","journal-title":"Science"},{"key":"2019111715423664700_B81","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2007-03-080044","article-title":"Mutations in the SBDS gene in acquired aplastic anemia.","volume":"110","author":"Calado","year":"2007","journal-title":"Blood"},{"key":"2019111715423664700_B82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ng1994","article-title":"The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast.","volume":"39","author":"Menne","year":"2007","journal-title":"Nat Genet"},{"key":"2019111715423664700_B83","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood-2007-02-075184","article-title":"The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA.","volume":"110","author":"Ganapathi","year":"2007","journal-title":"Blood"},{"key":"2019111715423664700_B84","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/blood-2006-03-007112","article-title":"Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential.","volume":"110","author":"Rawls","year":"2007","journal-title":"Blood"},{"key":"2019111715423664700_B85","doi-asserted-by":"crossref","first-page":"1639a","DOI":"10.1182\/blood.V108.11.1639.1639","article-title":"The SBDS gene regulates viability of myeloid precursor cells and is associated with high ROS production and telomere shortening in the SBDS downregulated cells [abstract].","volume":"108","author":"Yamaguchi","year":"2006","journal-title":"Blood"},{"key":"2019111715423664700_B86","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/35094086","article-title":"Cancer genetics: from Boveri and Mendel to microarrays.","volume":"1","author":"Balmain","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"2019111715423664700_B87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1101\/sqb.2005.70.032","article-title":"Telomere-related genome instability in cancer.","volume":"70","author":"de Lange","year":"2005","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"2019111715423664700_B88","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/ng0904-932","article-title":"Cancer chromosomes in crisis.","volume":"36","author":"DePinho","year":"2004","journal-title":"Nat Genet"},{"key":"2019111715423664700_B89","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/sj.onc.1205080","article-title":"Protection of mammalian telomeres.","volume":"21","author":"de Lange","year":"2002","journal-title":"Oncogene"},{"key":"2019111715423664700_B90","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ng989","article-title":"Chromosomal instability in ulcerative colitis is related to telomere shortening.","volume":"32","author":"O'Sullivan","year":"2002","journal-title":"Nat Genet"},{"key":"2019111715423664700_B91","doi-asserted-by":"crossref","first-page":"16a","DOI":"10.1182\/blood.V110.11.16.16","article-title":"Constitutional loss-of-function mutations in telomerase are genetic risk factors for acute myeloid leukemia [abstract].","volume":"110","author":"Calado","year":"2007","journal-title":"Blood"},{"key":"2019111715423664700_B92","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood.V30.2.251.251","article-title":"Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and \u201chypoplastic\u201d leukemia have in common?","volume":"30","author":"Dameshek","year":"1967","journal-title":"Blood"},{"key":"2019111715423664700_B93","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1182\/blood.V79.6.1385.1385","article-title":"The problem of clonality in aplastic anemia: Dr. Dameshek's riddle, restated.","volume":"79","author":"Young","year":"1992","journal-title":"Blood"},{"key":"2019111715423664700_B94","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V99.9.3129","article-title":"Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.","volume":"99","author":"Maciejewski","year":"2002","journal-title":"Blood"},{"key":"2019111715423664700_B95","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V108.11.2079.2079","article-title":"Telomere shortening and genomic instability: primary cells from patients with telomere repair complex mutations are susceptible to end-to-end chromosome fusion and aneuploidy.","volume":"108","author":"Sloand","year":"2006","journal-title":"Blood"},{"key":"2019111715423664700_B96","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.1998.00949.x","article-title":"Unusual complications after bone marrow transplantation for dyskeratosis congenita.","volume":"103","author":"Rocha","year":"1998","journal-title":"Brit J Haematol"},{"key":"2019111715423664700_B97","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0701009104","article-title":"Adult-onset pulmonary fibrosis caused by mutations in telomerase.","volume":"104","author":"Tsakiri","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715423664700_B98","doi-asserted-by":"crossref","first-page":"296a","DOI":"10.1182\/blood.V108.11.992.992","article-title":"A large Mennonite family with a novel K570N TERT gene mutation: association with a clinical spectrum of bone marrow failure, acute myeloid leukemia, and acute liver failure [abstract].","volume":"108","author":"Regal","year":"2006","journal-title":"Blood"},{"key":"2019111715423664700_B99","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.287.5456.1253","article-title":"Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.","volume":"287","author":"Rudolph","year":"2000","journal-title":"Science"},{"key":"2019111715423664700_B100","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"key":"2019111715423664700_B101","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.bmt.1703931","article-title":"Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita.","volume":"31","author":"Dror","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"2019111715423664700_B102","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1532\/IJH97.06030","article-title":"Intensive Immunosuppression therapy for Aplasti Anemia Associated with Dyskeratosis Congenita.","volume":"83","author":"Al-Rahawan","year":"2006","journal-title":"Int J Hematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/9\/4446\/1298555\/zh800908004446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/9\/4446\/1298555\/zh800908004446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T07:17:16Z","timestamp":1588317436000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/9\/4446\/24470\/Telomere-maintenance-and-human-bone-marrow-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,1]]},"references-count":102,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-08-019729","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,1]]}}}